Quantum-Si, Inc.

  • Market Cap: Micro Cap
  • Industry: Software Products
  • ISIN: US74765K1051
USD
1.47
0.2 (15.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.89 M

Shareholding (Mar 2025)

FII

11.57%

Held by 39 FIIs

DII

71.31%

Held by 23 DIIs

Promoter

1.14%

How big is Quantum-Si, Inc.?

22-Jun-2025

As of Jun 18, Quantum-Si, Inc. has a market capitalization of 308.28 million and reported net sales of 3.44 million with a net profit of -100.72 million over the last four quarters. The balance sheet shows shareholder's funds of 215.42 million and total assets of 247.87 million.

As of Jun 18, Quantum-Si, Inc. has a market capitalization of 308.28 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company's net sales for the latest four quarters totaled 3.44 million, while the net profit for the same period was reported at -100.72 million.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 215.42 million and total assets amounting to 247.87 million.

Read More

What does Quantum-Si, Inc. do?

22-Jun-2025

Quantum-Si, Inc. is a blank check company focused on acquiring and developing businesses in the life sciences sector, specifically within the Software Products industry. As of March 2025, it reported net sales of $1 million and a net loss of $19 million, with a market cap of $308.28 million.

Overview: <BR>Quantum-Si, Inc. is a blank check company focused on identifying, acquiring, and building a life sciences or life sciences-related business within the Software Products industry and operates in the micro-cap market.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -19 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 308.28 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.93 <BR>Return on Equity: -39.67% <BR>Price to Book: 1.25<BR><BR>Contact Details: <BR>Address: 452 Fifth Avenue, 21St Floor, NEW YORK NY: 10018 <BR>Tel: 1 212 5218495 <BR>Fax: 1 302 6365454

Read More

Should I buy, sell or hold Quantum-Si, Inc.?

22-Jun-2025

Is Quantum-Si, Inc. overvalued or undervalued?

20-Sep-2025

As of February 29, 2024, Quantum-Si, Inc. is classified as "risky" due to overvaluation based on key financial metrics, despite a recent strong weekly return of 27.50%, it has declined 43.33% year-to-date, highlighting its volatility and poor long-term performance.

As of 29 February 2024, Quantum-Si, Inc. has moved from a grade of "does not qualify" to "risky." The company is overvalued based on its current financial metrics. Key ratios include a Price to Book Value of 1.29, an EV to Capital Employed of 5.45, and an EV to Sales of 25.74. In comparison, MoneyLion, Inc. has a P/E ratio of 107.79, indicating a stark contrast in valuation metrics among peers, while Priority Technology Holdings, Inc. shows an EV to EBITDA of 7.55.<BR><BR>Despite a strong 1-week return of 27.50% compared to the S&P 500's 1.05%, Quantum-Si's year-to-date performance is concerning with a decline of 43.33% against the S&P's 12.22%. This volatility underscores the company's risky valuation status amid significant losses and negative returns over longer periods.

Read More

Is Quantum-Si, Inc. technically bullish or bearish?

20-Sep-2025

As of September 11, 2025, Quantum-Si, Inc. is in a mildly bearish trend despite recent outperformance against the S&P 500, with weekly indicators showing bearish signals while longer-term performance remains significantly negative.

As of 11 September 2025, the technical trend for Quantum-Si, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD and KST both indicating bearish signals, while the daily moving averages also reflect a mildly bearish outlook. The monthly indicators show some strength with the MACD and Bollinger Bands turning mildly bullish, but overall, the weekly signals dominate the analysis.<BR><BR>In terms of performance, Quantum-Si has outperformed the S&P 500 over the past week and month, with returns of 27.50% and 40.37% respectively, but it has significantly underperformed over longer periods, such as year-to-date and three years, where it shows returns of -43.33% and -47.78% compared to the S&P 500's positive returns.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Risky - Negative EBITDA

  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -1.46%, its profits have fallen by -11.2%
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Software Products

stock-summary
Market cap

USD 215 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.96

stock-summary
Return on Equity

-44.74%

stock-summary
Price to Book

0.97

Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-29 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
37.38%
0%
37.38%
6 Months
-16.48%
0%
-16.48%
1 Year
31.25%
0%
31.25%
2 Years
-15.52%
0%
-15.52%
3 Years
-40.96%
0%
-40.96%
4 Years
-74.43%
0%
-74.43%
5 Years
-85.23%
0%
-85.23%

Quantum-Si, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
44.91%
EBIT Growth (5y)
-219.46%
EBIT to Interest (avg)
-107.87
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.93
Sales to Capital Employed (avg)
0.01
Tax Ratio
0.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
41.38%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.29
EV to EBIT
-0.82
EV to EBITDA
-0.85
EV to Capital Employed
5.45
EV to Sales
25.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-665.68%
ROE (Latest)
-39.67%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 26 Schemes (15.98%)

Foreign Institutions

Held by 39 Foreign Institutions (11.57%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 200.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -24.68% vs 9.77% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-25.60",
          "val2": "-25.10",
          "chgp": "-1.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.40",
          "val2": "0.50",
          "chgp": "-980.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-28.80",
          "val2": "-23.10",
          "chgp": "-24.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-45,275.80%",
          "val2": "-42,525.70%",
          "chgp": "-275.01%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 181.82% vs 0.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -5.21% vs 27.49% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.10",
          "val2": "1.10",
          "chgp": "181.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-101.10",
          "val2": "-102.50",
          "chgp": "1.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.00",
          "val2": "0.80",
          "chgp": "-850.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-101.00",
          "val2": "-96.00",
          "chgp": "-5.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-34,768.80%",
          "val2": "-98,583.20%",
          "chgp": "6,381.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.60
0.60
Operating Profit (PBDIT) excl Other Income
-25.60
-25.10
-1.99%
Interest
0.00
0.00
Exceptional Items
-4.40
0.50
-980.00%
Consolidate Net Profit
-28.80
-23.10
-24.68%
Operating Profit Margin (Excl OI)
-45,275.80%
-42,525.70%
-275.01%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 200.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -24.68% vs 9.77% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3.10
1.10
181.82%
Operating Profit (PBDIT) excl Other Income
-101.10
-102.50
1.37%
Interest
0.00
0.00
Exceptional Items
-6.00
0.80
-850.00%
Consolidate Net Profit
-101.00
-96.00
-5.21%
Operating Profit Margin (Excl OI)
-34,768.80%
-98,583.20%
6,381.44%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 181.82% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -5.21% vs 27.49% in Dec 2023

stock-summaryCompany CV
About Quantum-Si, Inc. stock-summary
stock-summary
Quantum-Si, Inc.
Software Products
HighCape Capital Acquisition Corp. is a blank check company. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is focused on identifying, acquiring and building a life sciences or life sciences related business. The Company has conducted no operations and has generated no revenues.
Company Coordinates stock-summary
Company Details
452 Fifth Avenue, 21St Floor , NEW YORK NY : 10018
stock-summary
Tel: 1 212 5218495
stock-summary
stock-summary
Registrar Details